nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyldopa—Epinephrine—Dipivefrin—glaucoma	0.431	1	CrCrCtD
Methyldopa—ADRA2A—Apraclonidine—glaucoma	0.129	0.311	CbGbCtD
Methyldopa—ADRA2A—Brimonidine—glaucoma	0.129	0.311	CbGbCtD
Methyldopa—ADRA2A—Dipivefrin—glaucoma	0.103	0.249	CbGbCtD
Methyldopa—ADRA2A—Clonidine—glaucoma	0.0534	0.129	CbGbCtD
Methyldopa—DDC—Dopaminergic Neurogenesis—LMX1B—glaucoma	0.00323	0.164	CbGpPWpGaD
Methyldopa—DDC—Dopamine metabolism—SOD1—glaucoma	0.00128	0.0651	CbGpPWpGaD
Methyldopa—COMT—Dopamine metabolism—SOD1—glaucoma	0.00114	0.0578	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—ATOH7—glaucoma	0.00109	0.0554	CbGpPWpGaD
Methyldopa—COMT—Estrogen metabolism—CYP1B1—glaucoma	0.000986	0.05	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.000863	0.0437	CbGpPWpGaD
Methyldopa—COMT—Estrogen metabolism—GSTM1—glaucoma	0.000789	0.04	CbGpPWpGaD
Methyldopa—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A4—glaucoma	0.000626	0.0317	CbGpPWpGaD
Methyldopa—DDC—Tryptophan metabolism—CYP1B1—glaucoma	0.000524	0.0266	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—OPN4—glaucoma	0.000436	0.0221	CbGpPWpGaD
Methyldopa—COMT—Phase II conjugation—GSTT1—glaucoma	0.000348	0.0176	CbGpPWpGaD
Methyldopa—Flatulence—Brinzolamide—glaucoma	0.000317	0.00235	CcSEcCtD
Methyldopa—Rash—Metipranolol—glaucoma	0.000316	0.00234	CcSEcCtD
Methyldopa—Skin disorder—Apraclonidine—glaucoma	0.000316	0.00234	CcSEcCtD
Methyldopa—Dermatitis—Metipranolol—glaucoma	0.000316	0.00234	CcSEcCtD
Methyldopa—Asthenia—Levobunolol—glaucoma	0.000315	0.00233	CcSEcCtD
Methyldopa—Libido decreased—Timolol—glaucoma	0.000314	0.00233	CcSEcCtD
Methyldopa—Headache—Metipranolol—glaucoma	0.000314	0.00233	CcSEcCtD
Methyldopa—Infection—Bimatoprost—glaucoma	0.000314	0.00232	CcSEcCtD
Methyldopa—Nervous system disorder—Bimatoprost—glaucoma	0.00031	0.00229	CcSEcCtD
Methyldopa—DDC—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000309	0.0157	CbGpPWpGaD
Methyldopa—Dizziness—Carteolol—glaucoma	0.000307	0.00227	CcSEcCtD
Methyldopa—Skin disorder—Bimatoprost—glaucoma	0.000307	0.00227	CcSEcCtD
Methyldopa—Diarrhoea—Carbachol—glaucoma	0.000305	0.00226	CcSEcCtD
Methyldopa—Flatulence—Pilocarpine—glaucoma	0.000305	0.00225	CcSEcCtD
Methyldopa—Dizziness—Diclofenamide—glaucoma	0.000302	0.00224	CcSEcCtD
Methyldopa—Asthenia—Methazolamide—glaucoma	0.000302	0.00223	CcSEcCtD
Methyldopa—Diarrhoea—Levobunolol—glaucoma	0.000301	0.00222	CcSEcCtD
Methyldopa—Angina pectoris—Betaxolol—glaucoma	0.0003	0.00222	CcSEcCtD
Methyldopa—Nausea—Metipranolol—glaucoma	0.000298	0.00221	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Apraclonidine—glaucoma	0.000297	0.0022	CcSEcCtD
Methyldopa—Dizziness—Carbachol—glaucoma	0.000295	0.00218	CcSEcCtD
Methyldopa—Paraesthesia—Apraclonidine—glaucoma	0.000292	0.00216	CcSEcCtD
Methyldopa—Myalgia—Brimonidine—glaucoma	0.000292	0.00216	CcSEcCtD
Methyldopa—Arthralgia—Brimonidine—glaucoma	0.000292	0.00216	CcSEcCtD
Methyldopa—Headache—Carteolol—glaucoma	0.000291	0.00215	CcSEcCtD
Methyldopa—Vomiting—Diclofenamide—glaucoma	0.000291	0.00215	CcSEcCtD
Methyldopa—Dizziness—Levobunolol—glaucoma	0.00029	0.00215	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.00029	0.00214	CcSEcCtD
Methyldopa—Disturbance in sexual arousal—Timolol—glaucoma	0.000289	0.00214	CcSEcCtD
Methyldopa—Bradycardia—Clonidine—glaucoma	0.000289	0.00214	CcSEcCtD
Methyldopa—Rash—Diclofenamide—glaucoma	0.000288	0.00213	CcSEcCtD
Methyldopa—Diarrhoea—Methazolamide—glaucoma	0.000288	0.00213	CcSEcCtD
Methyldopa—Headache—Diclofenamide—glaucoma	0.000286	0.00212	CcSEcCtD
Methyldopa—Thrombocytopenia—Acetazolamide—glaucoma	0.000285	0.00211	CcSEcCtD
Methyldopa—Erectile dysfunction—Betaxolol—glaucoma	0.000284	0.0021	CcSEcCtD
Methyldopa—Vomiting—Carbachol—glaucoma	0.000284	0.0021	CcSEcCtD
Methyldopa—Hepatitis—Clonidine—glaucoma	0.000284	0.0021	CcSEcCtD
Methyldopa—COMT—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000283	0.0144	CbGpPWpGaD
Methyldopa—Rash—Carbachol—glaucoma	0.000281	0.00208	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Apraclonidine—glaucoma	0.000281	0.00208	CcSEcCtD
Methyldopa—Dermatitis—Carbachol—glaucoma	0.000281	0.00208	CcSEcCtD
Methyldopa—Weight increased—Betaxolol—glaucoma	0.000281	0.00208	CcSEcCtD
Methyldopa—SLC15A1—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.00028	0.0142	CbGpPWpGaD
Methyldopa—Oedema—Brimonidine—glaucoma	0.00028	0.00207	CcSEcCtD
Methyldopa—Headache—Carbachol—glaucoma	0.000279	0.00207	CcSEcCtD
Methyldopa—Arthralgia—Dorzolamide—glaucoma	0.000279	0.00206	CcSEcCtD
Methyldopa—Constipation—Apraclonidine—glaucoma	0.000278	0.00206	CcSEcCtD
Methyldopa—Infection—Brimonidine—glaucoma	0.000278	0.00206	CcSEcCtD
Methyldopa—Arthralgia—Travoprost—glaucoma	0.000277	0.00205	CcSEcCtD
Methyldopa—Myalgia—Travoprost—glaucoma	0.000277	0.00205	CcSEcCtD
Methyldopa—Leukopenia—Pilocarpine—glaucoma	0.000277	0.00205	CcSEcCtD
Methyldopa—Nausea—Carteolol—glaucoma	0.000276	0.00204	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.000275	0.00204	CcSEcCtD
Methyldopa—Headache—Levobunolol—glaucoma	0.000275	0.00204	CcSEcCtD
Methyldopa—Infestation—Betaxolol—glaucoma	0.000275	0.00204	CcSEcCtD
Methyldopa—Infestation NOS—Betaxolol—glaucoma	0.000275	0.00204	CcSEcCtD
Methyldopa—Nervous system disorder—Brimonidine—glaucoma	0.000274	0.00203	CcSEcCtD
Methyldopa—Arthralgia—Brinzolamide—glaucoma	0.000274	0.00203	CcSEcCtD
Methyldopa—Myalgia—Brinzolamide—glaucoma	0.000274	0.00203	CcSEcCtD
Methyldopa—Aminosalicylic Acid—PTGS2—glaucoma	0.000273	0.366	CrCbGaD
Methyldopa—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000273	0.00202	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000272	0.00201	CcSEcCtD
Methyldopa—Skin disorder—Brimonidine—glaucoma	0.000272	0.00201	CcSEcCtD
Methyldopa—Nausea—Diclofenamide—glaucoma	0.000271	0.00201	CcSEcCtD
Methyldopa—Dizziness—Latanoprost—glaucoma	0.000269	0.00199	CcSEcCtD
Methyldopa—Liver function test abnormal—Timolol—glaucoma	0.000269	0.00199	CcSEcCtD
Methyldopa—Vomiting—Methazolamide—glaucoma	0.000268	0.00198	CcSEcCtD
Methyldopa—Oedema—Dorzolamide—glaucoma	0.000267	0.00198	CcSEcCtD
Methyldopa—Oedema—Travoprost—glaucoma	0.000266	0.00197	CcSEcCtD
Methyldopa—Rash—Methazolamide—glaucoma	0.000265	0.00196	CcSEcCtD
Methyldopa—Dermatitis—Methazolamide—glaucoma	0.000265	0.00196	CcSEcCtD
Methyldopa—Nausea—Carbachol—glaucoma	0.000265	0.00196	CcSEcCtD
Methyldopa—Infection—Travoprost—glaucoma	0.000264	0.00195	CcSEcCtD
Methyldopa—Headache—Methazolamide—glaucoma	0.000264	0.00195	CcSEcCtD
Methyldopa—Breast disorder—Timolol—glaucoma	0.000263	0.00195	CcSEcCtD
Methyldopa—Cardiac disorder—Clonidine—glaucoma	0.000263	0.00195	CcSEcCtD
Methyldopa—Arthralgia—Pilocarpine—glaucoma	0.000263	0.00195	CcSEcCtD
Methyldopa—Myalgia—Pilocarpine—glaucoma	0.000263	0.00195	CcSEcCtD
Methyldopa—Paraesthesia—Acetazolamide—glaucoma	0.000262	0.00194	CcSEcCtD
Methyldopa—Nausea—Levobunolol—glaucoma	0.000261	0.00193	CcSEcCtD
Methyldopa—Infection—Brinzolamide—glaucoma	0.000261	0.00193	CcSEcCtD
Methyldopa—Nervous system disorder—Travoprost—glaucoma	0.000261	0.00193	CcSEcCtD
Methyldopa—Epinephrine—TNF—glaucoma	0.00026	0.348	CrCbGaD
Methyldopa—Skin disorder—Travoprost—glaucoma	0.000258	0.00191	CcSEcCtD
Methyldopa—Nervous system disorder—Brinzolamide—glaucoma	0.000257	0.0019	CcSEcCtD
Methyldopa—Angiopathy—Clonidine—glaucoma	0.000257	0.0019	CcSEcCtD
Methyldopa—Rash—Latanoprost—glaucoma	0.000257	0.0019	CcSEcCtD
Methyldopa—Agranulocytosis—Betaxolol—glaucoma	0.000257	0.0019	CcSEcCtD
Methyldopa—Dermatitis—Latanoprost—glaucoma	0.000257	0.0019	CcSEcCtD
Methyldopa—Mediastinal disorder—Clonidine—glaucoma	0.000256	0.00189	CcSEcCtD
Methyldopa—Headache—Latanoprost—glaucoma	0.000255	0.00189	CcSEcCtD
Methyldopa—Skin disorder—Brinzolamide—glaucoma	0.000255	0.00189	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000255	0.00188	CcSEcCtD
Methyldopa—Oedema—Pilocarpine—glaucoma	0.000252	0.00187	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000251	0.00186	CcSEcCtD
Methyldopa—Bradycardia—Betaxolol—glaucoma	0.000251	0.00186	CcSEcCtD
Methyldopa—Paraesthesia—Brimonidine—glaucoma	0.000251	0.00186	CcSEcCtD
Methyldopa—Infection—Pilocarpine—glaucoma	0.000251	0.00185	CcSEcCtD
Methyldopa—Nausea—Methazolamide—glaucoma	0.00025	0.00185	CcSEcCtD
Methyldopa—Mental disorder—Clonidine—glaucoma	0.000248	0.00184	CcSEcCtD
Methyldopa—Thrombocytopenia—Pilocarpine—glaucoma	0.000247	0.00183	CcSEcCtD
Methyldopa—Angina pectoris—Timolol—glaucoma	0.000245	0.00182	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000243	0.0018	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Travoprost—glaucoma	0.000242	0.00179	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Brimonidine—glaucoma	0.000241	0.00179	CcSEcCtD
Methyldopa—Hypersensitivity—Apraclonidine—glaucoma	0.00024	0.00178	CcSEcCtD
Methyldopa—Paraesthesia—Dorzolamide—glaucoma	0.00024	0.00177	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000239	0.00177	CcSEcCtD
Methyldopa—Paraesthesia—Brinzolamide—glaucoma	0.000236	0.00174	CcSEcCtD
Methyldopa—Asthenia—Apraclonidine—glaucoma	0.000234	0.00173	CcSEcCtD
Methyldopa—Erectile dysfunction—Timolol—glaucoma	0.000232	0.00172	CcSEcCtD
Methyldopa—Body temperature increased—Acetazolamide—glaucoma	0.00023	0.0017	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.00023	0.0017	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Travoprost—glaucoma	0.00023	0.0017	CcSEcCtD
Methyldopa—Cardiac disorder—Betaxolol—glaucoma	0.000229	0.0017	CcSEcCtD
Methyldopa—Constipation—Travoprost—glaucoma	0.000227	0.00168	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000227	0.00168	CcSEcCtD
Methyldopa—Paraesthesia—Pilocarpine—glaucoma	0.000227	0.00168	CcSEcCtD
Methyldopa—Asthenia—Bimatoprost—glaucoma	0.000227	0.00168	CcSEcCtD
Methyldopa—Angiopathy—Betaxolol—glaucoma	0.000224	0.00166	CcSEcCtD
Methyldopa—Diarrhoea—Apraclonidine—glaucoma	0.000223	0.00165	CcSEcCtD
Methyldopa—Mediastinal disorder—Betaxolol—glaucoma	0.000223	0.00165	CcSEcCtD
Methyldopa—COMT—Phase II conjugation—GSTM1—glaucoma	0.000222	0.0112	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000221	0.0112	CbGpPWpGaD
Methyldopa—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000218	0.00161	CcSEcCtD
Methyldopa—COMT—Neuronal System—SLC6A13—glaucoma	0.000217	0.011	CbGpPWpGaD
Methyldopa—Mental disorder—Betaxolol—glaucoma	0.000216	0.0016	CcSEcCtD
Methyldopa—Constipation—Pilocarpine—glaucoma	0.000216	0.0016	CcSEcCtD
Methyldopa—Dizziness—Apraclonidine—glaucoma	0.000215	0.00159	CcSEcCtD
Methyldopa—Mesalazine—PTGS2—glaucoma	0.000214	0.287	CrCbGaD
Methyldopa—Body temperature increased—Dorzolamide—glaucoma	0.000211	0.00156	CcSEcCtD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—PEX19—glaucoma	0.00021	0.0107	CbGpPWpGaD
Methyldopa—Arthralgia—Clonidine—glaucoma	0.00021	0.00156	CcSEcCtD
Methyldopa—Agranulocytosis—Timolol—glaucoma	0.00021	0.00155	CcSEcCtD
Methyldopa—Asthenia—Acetazolamide—glaucoma	0.000209	0.00155	CcSEcCtD
Methyldopa—Dizziness—Bimatoprost—glaucoma	0.000209	0.00154	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000209	0.00154	CcSEcCtD
Methyldopa—COMT—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000207	0.0105	CbGpPWpGaD
Methyldopa—Vomiting—Apraclonidine—glaucoma	0.000207	0.00153	CcSEcCtD
Methyldopa—Hypersensitivity—Brimonidine—glaucoma	0.000206	0.00152	CcSEcCtD
Methyldopa—Bradycardia—Timolol—glaucoma	0.000205	0.00152	CcSEcCtD
Methyldopa—Dermatitis—Apraclonidine—glaucoma	0.000205	0.00152	CcSEcCtD
Methyldopa—Headache—Apraclonidine—glaucoma	0.000204	0.00151	CcSEcCtD
Methyldopa—COMT—Biological oxidations—GSTT1—glaucoma	0.000203	0.0103	CbGpPWpGaD
Methyldopa—Oedema—Clonidine—glaucoma	0.000201	0.00149	CcSEcCtD
Methyldopa—Asthenia—Brimonidine—glaucoma	0.000201	0.00148	CcSEcCtD
Methyldopa—Infection—Clonidine—glaucoma	0.0002	0.00148	CcSEcCtD
Methyldopa—Body temperature increased—Pilocarpine—glaucoma	0.000199	0.00148	CcSEcCtD
Methyldopa—Diarrhoea—Acetazolamide—glaucoma	0.000199	0.00147	CcSEcCtD
Methyldopa—Rash—Bimatoprost—glaucoma	0.000199	0.00147	CcSEcCtD
Methyldopa—Dermatitis—Bimatoprost—glaucoma	0.000199	0.00147	CcSEcCtD
Methyldopa—Connective tissue disorder—Timolol—glaucoma	0.000198	0.00147	CcSEcCtD
Methyldopa—Headache—Bimatoprost—glaucoma	0.000198	0.00146	CcSEcCtD
Methyldopa—Nervous system disorder—Clonidine—glaucoma	0.000198	0.00146	CcSEcCtD
Methyldopa—Thrombocytopenia—Clonidine—glaucoma	0.000197	0.00146	CcSEcCtD
Methyldopa—Hypersensitivity—Dorzolamide—glaucoma	0.000197	0.00146	CcSEcCtD
Methyldopa—Hypersensitivity—Travoprost—glaucoma	0.000196	0.00145	CcSEcCtD
Methyldopa—Skin disorder—Clonidine—glaucoma	0.000196	0.00145	CcSEcCtD
Methyldopa—Nausea—Apraclonidine—glaucoma	0.000193	0.00143	CcSEcCtD
Methyldopa—Hypersensitivity—Brinzolamide—glaucoma	0.000193	0.00143	CcSEcCtD
Methyldopa—Dizziness—Acetazolamide—glaucoma	0.000193	0.00143	CcSEcCtD
Methyldopa—Asthenia—Dorzolamide—glaucoma	0.000192	0.00142	CcSEcCtD
Methyldopa—Asthenia—Travoprost—glaucoma	0.000191	0.00141	CcSEcCtD
Methyldopa—Asthenia—Brinzolamide—glaucoma	0.000188	0.00139	CcSEcCtD
Methyldopa—Nausea—Bimatoprost—glaucoma	0.000188	0.00139	CcSEcCtD
Methyldopa—Cardiac disorder—Timolol—glaucoma	0.000187	0.00139	CcSEcCtD
Methyldopa—SLC15A1—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000187	0.00946	CbGpPWpGaD
Methyldopa—Hypersensitivity—Pilocarpine—glaucoma	0.000186	0.00138	CcSEcCtD
Methyldopa—Vomiting—Acetazolamide—glaucoma	0.000185	0.00137	CcSEcCtD
Methyldopa—Dizziness—Brimonidine—glaucoma	0.000185	0.00137	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Clonidine—glaucoma	0.000184	0.00136	CcSEcCtD
Methyldopa—Angiopathy—Timolol—glaucoma	0.000183	0.00135	CcSEcCtD
Methyldopa—Myalgia—Betaxolol—glaucoma	0.000183	0.00135	CcSEcCtD
Methyldopa—Arthralgia—Betaxolol—glaucoma	0.000183	0.00135	CcSEcCtD
Methyldopa—Diarrhoea—Dorzolamide—glaucoma	0.000183	0.00135	CcSEcCtD
Methyldopa—Headache—Acetazolamide—glaucoma	0.000182	0.00135	CcSEcCtD
Methyldopa—Diarrhoea—Travoprost—glaucoma	0.000182	0.00135	CcSEcCtD
Methyldopa—Mediastinal disorder—Timolol—glaucoma	0.000182	0.00135	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000182	0.00134	CcSEcCtD
Methyldopa—Asthenia—Pilocarpine—glaucoma	0.000181	0.00134	CcSEcCtD
Methyldopa—Paraesthesia—Clonidine—glaucoma	0.000181	0.00134	CcSEcCtD
Methyldopa—Diarrhoea—Brinzolamide—glaucoma	0.00018	0.00133	CcSEcCtD
Methyldopa—Mental disorder—Timolol—glaucoma	0.000177	0.00131	CcSEcCtD
Methyldopa—Dizziness—Dorzolamide—glaucoma	0.000177	0.00131	CcSEcCtD
Methyldopa—Rash—Brimonidine—glaucoma	0.000176	0.0013	CcSEcCtD
Methyldopa—Dermatitis—Brimonidine—glaucoma	0.000176	0.0013	CcSEcCtD
Methyldopa—Dizziness—Travoprost—glaucoma	0.000176	0.0013	CcSEcCtD
Methyldopa—Oedema—Betaxolol—glaucoma	0.000175	0.0013	CcSEcCtD
Methyldopa—Headache—Brimonidine—glaucoma	0.000175	0.0013	CcSEcCtD
Methyldopa—Infection—Betaxolol—glaucoma	0.000174	0.00129	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Clonidine—glaucoma	0.000174	0.00129	CcSEcCtD
Methyldopa—Dizziness—Brinzolamide—glaucoma	0.000174	0.00128	CcSEcCtD
Methyldopa—Nausea—Acetazolamide—glaucoma	0.000173	0.00128	CcSEcCtD
Methyldopa—Diarrhoea—Pilocarpine—glaucoma	0.000173	0.00128	CcSEcCtD
Methyldopa—Constipation—Clonidine—glaucoma	0.000172	0.00127	CcSEcCtD
Methyldopa—Nervous system disorder—Betaxolol—glaucoma	0.000172	0.00127	CcSEcCtD
Methyldopa—Thrombocytopenia—Betaxolol—glaucoma	0.000172	0.00127	CcSEcCtD
Methyldopa—Skin disorder—Betaxolol—glaucoma	0.00017	0.00126	CcSEcCtD
Methyldopa—Vomiting—Dorzolamide—glaucoma	0.00017	0.00126	CcSEcCtD
Methyldopa—Rash—Dorzolamide—glaucoma	0.000168	0.00125	CcSEcCtD
Methyldopa—Dermatitis—Dorzolamide—glaucoma	0.000168	0.00124	CcSEcCtD
Methyldopa—Rash—Travoprost—glaucoma	0.000168	0.00124	CcSEcCtD
Methyldopa—Dermatitis—Travoprost—glaucoma	0.000167	0.00124	CcSEcCtD
Methyldopa—Headache—Dorzolamide—glaucoma	0.000167	0.00124	CcSEcCtD
Methyldopa—Vomiting—Brinzolamide—glaucoma	0.000167	0.00123	CcSEcCtD
Methyldopa—Dizziness—Pilocarpine—glaucoma	0.000167	0.00123	CcSEcCtD
Methyldopa—Headache—Travoprost—glaucoma	0.000167	0.00123	CcSEcCtD
Methyldopa—Nausea—Brimonidine—glaucoma	0.000166	0.00123	CcSEcCtD
Methyldopa—Rash—Brinzolamide—glaucoma	0.000166	0.00122	CcSEcCtD
Methyldopa—Dermatitis—Brinzolamide—glaucoma	0.000165	0.00122	CcSEcCtD
Methyldopa—DDC—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000165	0.00838	CbGpPWpGaD
Methyldopa—Headache—Brinzolamide—glaucoma	0.000164	0.00122	CcSEcCtD
Methyldopa—COMT—Biological oxidations—CYP1B1—glaucoma	0.000162	0.00821	CbGpPWpGaD
Methyldopa—DDC—Metabolism—NARFL—glaucoma	0.000161	0.00814	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CA5A—glaucoma	0.000161	0.00814	CbGpPWpGaD
Methyldopa—Vomiting—Pilocarpine—glaucoma	0.00016	0.00119	CcSEcCtD
Methyldopa—COMT—Metapathway biotransformation—CYP1B1—glaucoma	0.00016	0.0081	CbGpPWpGaD
Methyldopa—Musculoskeletal discomfort—Betaxolol—glaucoma	0.00016	0.00118	CcSEcCtD
Methyldopa—Body temperature increased—Clonidine—glaucoma	0.000159	0.00118	CcSEcCtD
Methyldopa—Rash—Pilocarpine—glaucoma	0.000159	0.00118	CcSEcCtD
Methyldopa—Dermatitis—Pilocarpine—glaucoma	0.000159	0.00118	CcSEcCtD
Methyldopa—COMT—Neuronal System—SLC6A1—glaucoma	0.000159	0.00805	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000159	0.00804	CbGpPWpGaD
Methyldopa—Nausea—Dorzolamide—glaucoma	0.000159	0.00117	CcSEcCtD
Methyldopa—Headache—Pilocarpine—glaucoma	0.000158	0.00117	CcSEcCtD
Methyldopa—Nausea—Travoprost—glaucoma	0.000158	0.00117	CcSEcCtD
Methyldopa—Paraesthesia—Betaxolol—glaucoma	0.000158	0.00117	CcSEcCtD
Methyldopa—Nausea—Brinzolamide—glaucoma	0.000156	0.00115	CcSEcCtD
Methyldopa—DDC—Circadian rythm related genes—NGFR—glaucoma	0.000155	0.00786	CbGpPWpGaD
Methyldopa—Gastrointestinal disorder—Betaxolol—glaucoma	0.000151	0.00112	CcSEcCtD
Methyldopa—Constipation—Betaxolol—glaucoma	0.00015	0.00111	CcSEcCtD
Methyldopa—Nausea—Pilocarpine—glaucoma	0.00015	0.00111	CcSEcCtD
Methyldopa—Arthralgia—Timolol—glaucoma	0.000149	0.00111	CcSEcCtD
Methyldopa—Myalgia—Timolol—glaucoma	0.000149	0.00111	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000148	0.0011	CcSEcCtD
Methyldopa—Hypersensitivity—Clonidine—glaucoma	0.000148	0.0011	CcSEcCtD
Methyldopa—DDC—Circadian rythm related genes—NTRK1—glaucoma	0.000147	0.00747	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—NGF—glaucoma	0.000147	0.00743	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000146	0.0074	CbGpPWpGaD
Methyldopa—Asthenia—Clonidine—glaucoma	0.000145	0.00107	CcSEcCtD
Methyldopa—Oedema—Timolol—glaucoma	0.000143	0.00106	CcSEcCtD
Methyldopa—COMT—Metabolism—CA5A—glaucoma	0.000143	0.00723	CbGpPWpGaD
Methyldopa—COMT—Metabolism—NARFL—glaucoma	0.000143	0.00723	CbGpPWpGaD
Methyldopa—Infection—Timolol—glaucoma	0.000142	0.00105	CcSEcCtD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000142	0.0072	CbGpPWpGaD
Methyldopa—Nervous system disorder—Timolol—glaucoma	0.000141	0.00104	CcSEcCtD
Methyldopa—Skin disorder—Timolol—glaucoma	0.000139	0.00103	CcSEcCtD
Methyldopa—Body temperature increased—Betaxolol—glaucoma	0.000139	0.00103	CcSEcCtD
Methyldopa—Diarrhoea—Clonidine—glaucoma	0.000138	0.00102	CcSEcCtD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.000138	0.00697	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet Aggregation (Plug Formation)—FN1—glaucoma	0.000137	0.00692	CbGpPWpGaD
Methyldopa—SLC15A1—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000137	0.00692	CbGpPWpGaD
Methyldopa—Dizziness—Clonidine—glaucoma	0.000133	0.000986	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Timolol—glaucoma	0.000131	0.000966	CcSEcCtD
Methyldopa—COMT—Biological oxidations—GSTM1—glaucoma	0.00013	0.00657	CbGpPWpGaD
Methyldopa—Hypersensitivity—Betaxolol—glaucoma	0.000129	0.000956	CcSEcCtD
Methyldopa—Paraesthesia—Timolol—glaucoma	0.000129	0.000952	CcSEcCtD
Methyldopa—Vomiting—Clonidine—glaucoma	0.000128	0.000948	CcSEcCtD
Methyldopa—COMT—Metapathway biotransformation—GSTM1—glaucoma	0.000128	0.00648	CbGpPWpGaD
Methyldopa—Rash—Clonidine—glaucoma	0.000127	0.00094	CcSEcCtD
Methyldopa—Dermatitis—Clonidine—glaucoma	0.000127	0.000939	CcSEcCtD
Methyldopa—Headache—Clonidine—glaucoma	0.000126	0.000934	CcSEcCtD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000126	0.00638	CbGpPWpGaD
Methyldopa—Asthenia—Betaxolol—glaucoma	0.000126	0.000931	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Timolol—glaucoma	0.000124	0.000915	CcSEcCtD
Methyldopa—Diarrhoea—Betaxolol—glaucoma	0.00012	0.000888	CcSEcCtD
Methyldopa—Nausea—Clonidine—glaucoma	0.00012	0.000886	CcSEcCtD
Methyldopa—Dizziness—Betaxolol—glaucoma	0.000116	0.000858	CcSEcCtD
Methyldopa—DDC—Circadian rythm related genes—FAS—glaucoma	0.000116	0.00585	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000113	0.00574	CbGpPWpGaD
Methyldopa—Body temperature increased—Timolol—glaucoma	0.000113	0.000838	CcSEcCtD
Methyldopa—Vomiting—Betaxolol—glaucoma	0.000112	0.000825	CcSEcCtD
Methyldopa—Rash—Betaxolol—glaucoma	0.000111	0.000818	CcSEcCtD
Methyldopa—Dermatitis—Betaxolol—glaucoma	0.00011	0.000818	CcSEcCtD
Methyldopa—Headache—Betaxolol—glaucoma	0.00011	0.000813	CcSEcCtD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000108	0.00546	CbGpPWpGaD
Methyldopa—Hypersensitivity—Timolol—glaucoma	0.000106	0.000781	CcSEcCtD
Methyldopa—Nausea—Betaxolol—glaucoma	0.000104	0.000771	CcSEcCtD
Methyldopa—Asthenia—Timolol—glaucoma	0.000103	0.000761	CcSEcCtD
Methyldopa—Diarrhoea—Timolol—glaucoma	9.8e-05	0.000725	CcSEcCtD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	9.71e-05	0.00492	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—SLC6A13—glaucoma	9.48e-05	0.00481	CbGpPWpGaD
Methyldopa—Dizziness—Timolol—glaucoma	9.48e-05	0.000701	CcSEcCtD
Methyldopa—Vomiting—Timolol—glaucoma	9.11e-05	0.000674	CcSEcCtD
Methyldopa—Rash—Timolol—glaucoma	9.03e-05	0.000669	CcSEcCtD
Methyldopa—Dermatitis—Timolol—glaucoma	9.03e-05	0.000668	CcSEcCtD
Methyldopa—Headache—Timolol—glaucoma	8.98e-05	0.000664	CcSEcCtD
Methyldopa—Nausea—Timolol—glaucoma	8.51e-05	0.00063	CcSEcCtD
Methyldopa—ADRA2A—GPCR ligand binding—OPN4—glaucoma	8.21e-05	0.00416	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CA1—glaucoma	7.84e-05	0.00397	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CTSA—glaucoma	7.6e-05	0.00385	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—PTGFR—glaucoma	7.39e-05	0.00375	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CA2—glaucoma	7.17e-05	0.00363	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—VEGFA—glaucoma	7.01e-05	0.00355	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CA1—glaucoma	6.96e-05	0.00353	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—SLC6A1—glaucoma	6.94e-05	0.00352	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CTSA—glaucoma	6.74e-05	0.00342	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CA2—glaucoma	6.37e-05	0.00323	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—TGFB2—glaucoma	6.2e-05	0.00314	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—TNF—glaucoma	6.01e-05	0.00304	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CA5A—glaucoma	5.67e-05	0.00287	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—NARFL—glaucoma	5.67e-05	0.00287	CbGpPWpGaD
Methyldopa—DDC—Metabolism—TXN—glaucoma	5.05e-05	0.00256	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—SOD1—glaucoma	4.7e-05	0.00238	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—OPN4—glaucoma	4.64e-05	0.00235	CbGpPWpGaD
Methyldopa—COMT—Metabolism—TXN—glaucoma	4.49e-05	0.00227	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—TP53—glaucoma	4.32e-05	0.00219	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—OPN4—glaucoma	4.21e-05	0.00214	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—PTGFR—glaucoma	4.18e-05	0.00212	CbGpPWpGaD
Methyldopa—DDC—Metabolism—GSTT1—glaucoma	3.92e-05	0.00199	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PTGFR—glaucoma	3.79e-05	0.00192	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—SMO—glaucoma	3.73e-05	0.00189	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—LRP12—glaucoma	3.59e-05	0.00182	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—C3—glaucoma	3.55e-05	0.0018	CbGpPWpGaD
Methyldopa—COMT—Metabolism—GSTT1—glaucoma	3.48e-05	0.00176	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—FN1—glaucoma	3.27e-05	0.00166	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	3.23e-05	0.00164	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—TGFB2—glaucoma	3.2e-05	0.00162	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CYP1B1—glaucoma	3.12e-05	0.00158	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ABCA1—glaucoma	3.12e-05	0.00158	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.82e-05	0.00143	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CYP1B1—glaucoma	2.77e-05	0.0014	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ABCA1—glaucoma	2.77e-05	0.0014	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CA1—glaucoma	2.77e-05	0.0014	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CTSA—glaucoma	2.68e-05	0.00136	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CA2—glaucoma	2.53e-05	0.00128	CbGpPWpGaD
Methyldopa—DDC—Metabolism—GSTM1—glaucoma	2.5e-05	0.00126	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—OPN4—glaucoma	2.49e-05	0.00126	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—EDN1—glaucoma	2.46e-05	0.00125	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—SOD1—glaucoma	2.42e-05	0.00123	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HEYL—glaucoma	2.31e-05	0.00117	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PTGFR—glaucoma	2.24e-05	0.00114	CbGpPWpGaD
Methyldopa—COMT—Metabolism—GSTM1—glaucoma	2.22e-05	0.00112	CbGpPWpGaD
Methyldopa—DDC—Metabolism—MTHFR—glaucoma	2.21e-05	0.00112	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—C3—glaucoma	2.15e-05	0.00109	CbGpPWpGaD
Methyldopa—DDC—Metabolism—APOE—glaucoma	2.05e-05	0.00104	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CAV1—glaucoma	2.03e-05	0.00103	CbGpPWpGaD
Methyldopa—COMT—Metabolism—MTHFR—glaucoma	1.96e-05	0.000993	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—SMO—glaucoma	1.91e-05	0.000969	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—glaucoma	1.87e-05	0.000948	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—MMP1—glaucoma	1.85e-05	0.000936	CbGpPWpGaD
Methyldopa—COMT—Metabolism—APOE—glaucoma	1.82e-05	0.000924	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CAV1—glaucoma	1.81e-05	0.000915	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—TXN—glaucoma	1.78e-05	0.000904	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—CAV1—glaucoma	1.77e-05	0.000897	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—RPTOR—glaucoma	1.75e-05	0.000889	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NCK2—glaucoma	1.7e-05	0.000861	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—FN1—glaucoma	1.69e-05	0.000854	CbGpPWpGaD
Methyldopa—DDC—Metabolism—NOS3—glaucoma	1.54e-05	0.00078	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HDAC9—glaucoma	1.44e-05	0.000732	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PTGS2—glaucoma	1.41e-05	0.000713	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—EDN1—glaucoma	1.39e-05	0.000704	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GSTT1—glaucoma	1.38e-05	0.000701	CbGpPWpGaD
Methyldopa—COMT—Metabolism—NOS3—glaucoma	1.37e-05	0.000692	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—NOS3—glaucoma	1.34e-05	0.000679	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—EDN1—glaucoma	1.26e-05	0.000639	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PTGS2—glaucoma	1.25e-05	0.000633	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—C3—glaucoma	1.21e-05	0.000615	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—SMO—glaucoma	1.13e-05	0.000573	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—C3—glaucoma	1.1e-05	0.000558	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ABCA1—glaucoma	1.1e-05	0.000558	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CYP1B1—glaucoma	1.1e-05	0.000558	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NTRK2—glaucoma	1.03e-05	0.000524	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—VEGFA—glaucoma	9.65e-06	0.000489	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NGFR—glaucoma	8.87e-06	0.000449	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GSTM1—glaucoma	8.81e-06	0.000446	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NTRK1—glaucoma	8.43e-06	0.000427	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—MTHFR—glaucoma	7.78e-06	0.000394	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CDKN2B—glaucoma	7.77e-06	0.000393	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—EDN1—glaucoma	7.45e-06	0.000378	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—TP53—glaucoma	7.29e-06	0.000369	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—APOE—glaucoma	7.25e-06	0.000367	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CAV1—glaucoma	7.18e-06	0.000364	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NGF—glaucoma	6.85e-06	0.000347	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—C3—glaucoma	6.51e-06	0.00033	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—APOE—glaucoma	6.06e-06	0.000307	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CAV1—glaucoma	6e-06	0.000304	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—FN1—glaucoma	5.71e-06	0.00029	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—BAD—glaucoma	5.65e-06	0.000286	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—NOS3—glaucoma	5.43e-06	0.000275	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PTGS2—glaucoma	4.97e-06	0.000252	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NOS3—glaucoma	4.54e-06	0.00023	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CDKN1B—glaucoma	3.93e-06	0.000199	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—MMP9—glaucoma	3.64e-06	0.000185	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—VEGFA—glaucoma	3.27e-06	0.000166	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TP53—glaucoma	2.47e-06	0.000125	CbGpPWpGaD
